NEW YORK, Nov. 23, 2015 /PRNewswire/ -- Neuragain, LLC (www.neuragain.com & www.neuragainproviders.com), which is now recruiting doctors around the country to join its growing network of affiliates, has announced the launch of its first physician office in Manhattan, New York.
Amanda Itzkoff, MD, a leading Manhattan psychiatrist, has added Neuragain's cutting-edge treatments for depression, anxiety and other conditions to her existing practice. These treatments include ketamine infusion therapy, a highly-effective way to alleviate symptoms of major depression that have not responded to other remedies.
Dr. Itzkoff is a graduate of Cornell University (where she was co-valedictorian) and the New York University School of Medicine. She completed the Mount Sinai Residency Training Program in Psychiatry, as well as a Mount Sinai Fellowship, and now serves on the faculty at Mount Sinai Hospital. She is the recipient of many awards, including the Most Compassionate Doctor Award, the Patients' Choice Award and the Adele Zinbeg Award for Women's Leadership in Psychiatry.
"I have always been committed to bringing every resource to the patients I treat," Dr. Itzkoff said. "Joining the Neuragain network means I can offer them even more."
"We are very pleased that Dr. Itzkoff recognizes the tremendous impact which Neuragain's treatments can have on the suffering of people with depression and other conditions," said Henrik Sandell, PhD, CEO of Neuragain. "Doctors around the country are seeing the benefits that a relationship with Neuragain can deliver to their patients and their practices."
Neuragain's Advisory Board boasts some of the most esteemed clinicians and medical educators in the world, including Alexander Vuckovic, MD, Distinguished Fellow of the American Psychiatric Association and Medical Director of the Pavilion at McLean Hospital, as well as Sanjiv Chopra, MD, MACP, Professor of Medicine at Harvard Medical School and the former Faculty Dean for Continuing Education at Harvard Medical School.
"When internists, family physicians or psychiatrists decide to add Neuragain to their practices," said Dr. Sandell, "it means that those doctors have decided to focus in very unique and powerful ways on brain health and performance. These doctors will see their practices expand for the best imaginable reason—because they will be delivering very effective treatments not generally available elsewhere."
ABOUT Neuragain, LLC: Neuragain empowers physicians and their patients to utilize treatment protocols that are safe and effective, free from the intercession of insurance companies whose motivations are fundamentally cost driven and increasingly at odds with the patient's best interest. Neuragain physicians deliver state-of-the-art care in their offices and offer patients a comfortable, familiar, and local, option for treatment protocols that, in the past, have required travel.
Now more than ever, patients with treatment resistant illnesses are empowered to take a proactive approach to restoring their good health. Neuragain physicians welcome the opportunity to work with informed health care consumers and are committed to providing an unparalleled patient experience and superior outcomes.
SOURCE Neuragain, LLC